Marmorstein Lihua
Department of Ophthalmology, University of Arizona, Tuscon, USA.
Ophthalmic Genet. 2004 Sep;25(3):219-26. doi: 10.1080/13816810490498305.
Malattia leventinese (ML) or Doyne honeycomb retinal dystrophy (DHRD) was the first clinically and histopathologically described Mendelian maculopathy. The gene responsible for ML/DHRD, EFEMPI (fibulin-3/SI-5/FBNL) encodes a member of the fibulin family, a newly recognized family of extracellular matrix proteins. EFEMPImutations have not been found in age-related macular degeneration (AMD) patients despite the close phenotypic similarities between ML/DHRD and AMD. This non-correlating genotype/phenotype relationship between inherited and age-related conditions is typical for common age-related diseases. Biochemical pathways delineated in other diseases indicate that the gene associated with the inherited condition is nonetheless critical in age-related forms. This review summarizes current knowledge relating to ML/DHRD and EFEMPI,with discussion of why EFEMPI mutations are absent in AMD and how EFEMPI may be involved in the pathogenesis of ML/DHRD and AMD.
莱文廷内斯病(ML)或多伊内蜂窝状视网膜营养不良(DHRD)是首个在临床和组织病理学上被描述的孟德尔遗传性黄斑病变。导致ML/DHRD的基因EFEMPI(纤连蛋白-3/SI-5/FBNL)编码纤连蛋白家族的一个成员,纤连蛋白家族是新发现的细胞外基质蛋白家族。尽管ML/DHRD与年龄相关性黄斑变性(AMD)在表型上有密切相似之处,但在AMD患者中未发现EFEMPI突变。这种遗传性疾病与年龄相关性疾病之间不相关的基因型/表型关系在常见的年龄相关性疾病中很典型。在其他疾病中描述的生化途径表明,与遗传性疾病相关的基因在年龄相关性疾病形式中仍然至关重要。本综述总结了与ML/DHRD和EFEMPI相关的当前知识,讨论了为什么AMD中不存在EFEMPI突变以及EFEMPI可能如何参与ML/DHRD和AMD的发病机制。